OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2025
(5)
2023
(5)
2024
(2)
2022
(2)
2019
(2)
2021
(1)
2020
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Computational modeling of in vitro biological responses on polymethacrylate surfaces.
Not available
S-EPMC3138629
|
biostudies-literature
Cite
Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviour.
Not available
S-EPMC12047813
|
biostudies-literature
Cite
Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial.
Not available
S-EPMC12100857
|
biostudies-literature
Cite
Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls.
Not available
S-EPMC11249223
|
biostudies-literature
Cite
Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trial.
Not available
S-EPMC12334910
|
biostudies-literature
Cite
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.
Not available
S-EPMC6726557
|
biostudies-literature
Cite
Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial.
Not available
S-EPMC6756327
|
biostudies-literature
Cite
The impact of a tailored nutrition intervention delivered for the duration of hospitalisation on daily energy delivery for patients with critical illness (INTENT): a phase II randomised controlled trial.
Not available
S-EPMC11706088
|
biostudies-literature
Cite
Stratified analyses refine association between TLR7 rare variants and severe COVID-19.
Not available
S-EPMC11320601
|
biostudies-literature
Cite
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Not available
S-EPMC10208981
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets